Medicxi
London · Invests in London, United Kingdom · Website
Check size
🔒 $•• – $••Thesis
European life-sciences investment firm established in 2016 by the former Index Ventures life sciences team. Creates and backs biotech companies across the full drug development continuum, from discovery through pivotal studies and registration, using a pioneering 'asset-centric' virtual-company model with deliberately light governance. LPs include GSK, Johnson & Johnson Innovation (JJDC), Novartis and Verily.
Profile drafted from public signals. Our research team reviews every firm.
Partners & team
14 contacts on file
Medicxi in the news
Fierce Biotech
Ethyreal Bio manifests with $101M in pack of biotechs gunning for Amgen’s Tepezza
2 months ago
Axios
Eli Lilly spending $3.8 billion to buy vaccine makers
3 months ago
Dealroom
Cash Flood: Medicxi Unleashes Half-Billion-Euro War Chest on High-Impact Biotechs
4 months ago
Yahoo Finance
Medicxi unveils €500m fund for asset-centric biotechs
9 months ago
Pharmaceutical Technology
Medicxi unveils €500m fund for asset-centric biotechs
9 months ago
Silicon Canals
European life sciences VC firm Medicxi closes €500M Fund V: Know more
9 months ago
European Biotechnology Magazine
Medicxi announces new €500m biotech investment fund
9 months ago
BioXconomy
Medicxi closes $581m Fund V to accelerate asset-centric biotech investments
9 months ago
pharmaphorum.com
Medicxi raises €500m for latest biotech fund
9 months ago
Venture Capital Journal
Index spinout Medicxi closes Fund V at €500m
9 months ago
FirstWord Pharma
Medicxi closes sixth fund at €500M, touts success of asset-focused mentality
9 months ago
thepharmaletter.com
Medicxi announces 500 million-euro Fund V
9 months ago
Endpoints News
Medicxi, which backed Vicebio and Versanis, closes new €500M biotech fund
9 months ago
BioPharma Dive
Medicxi closes sixth fund to back ‘asset-centric’ startups
9 months ago
Fierce Biotech
European investor Medicxi secures €500M biotech fund
9 months ago
Crunchbase
Medicxi - Financial Details
Jul 2025
Fierce Biotech
Medicxi merges 6 dermatology biotechs into one, adds $100M funding for launch
Feb 2024
Endpoints News
The veteran crew at Medicxi is back with a new $400M fund and an upbeat assessment of what's coming
Jul 2023
BioPharma Dive
European VC Medicxi raises $400M for ‘asset-centric’ biotech investing
Jul 2023
BioPharma Dive
Incyte, branching out in dermatology, to buy startup Villaris
Oct 2022
Fierce Biotech
Medicxi raises €200M to take 6 biotechs deeper into the clinic
Sep 2020
Fierce Biotech
J&J, Novartis help Medicxi raise €400M biopharma fund
Jul 2019
Venture Capital Journal
Biotech-focused Medicxi forges separate dynasty
Feb 2016
Add Medicxi to your investor list
Sign up free to save investors, see partner contacts, and track your raise.
Sign up